5-HT2 modulators (Synaptic/Lilly)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Name5-HT2 modulators (Synaptic/Lilly)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 2 (5-HT2) receptor modulators
TargetsSerotonin 2a (5-HT2a) receptorSerotonin 2 (5-HT2) receptor
Therapy Area/IndicationsAnxiety DisordersHypertensionUrethral Diseases +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesWorldItaly +[8] 
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLundbeck Research Usa Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLundbeck Research Usa IncEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsAnxiety DisordersHypertensionUrethral Diseases +[5] 

Other Information

ATC CodeN/A
Related LinksN/A